NU100
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NU100, covering 2013-09-23 to 2013-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 3]